COMBINATION THERAPY WITH AN ANTI-CA19-9 ANTIBODY AND FOLFIRINOX IN THE TREATMENT OF CANCER Application WO-2022200498-A1 World Intellectual Property Organisation (WIPO) 29 Sep 2022